Table 2.
Chemokine | Patients Analyzed (n) |
Median ( pg/mL) |
25th Percentil e (pg/mL) |
75th Percenti le (pg/mL) |
Detection Limit (pg/mL) |
---|---|---|---|---|---|
CXCL1 | 207 | 29.24 | 21.6 | 44.29 | 9.9 |
CXCL8 | 207 | 8.48 | 3.52 | 20.45 | 0.4 |
CXCL10 | 207 | 82.46 | 30.32 | 162 | 8.6 |
sIL-1RA | 207 | 89.18 | 36.93 | 215.88 | 8.3 |
CCL2 | 207 | 316.29 | 168.24 | 616.04 | 1.9 |
CCL3 | 207 | 4.63 | 3.92 | 5.18 | 2.9 |
CCL5 | 118 | 13.10 | 6.46 | 20.74 | 1.2 |
sCD40L | 177 | 6.54 | 5.84 | 8.06 | 5.1 |
PDGF-BB | 118 | 29.57 | 14.64 | 38.87 | 2.2 |
IL-6 | 118 | 3.26 | 1.82 | 5.06 | 0.9 |
IL-17 | 177 | 0.90 | 0.77 | 1.01 | 0.7 |
CCL2, CXCL-8 and sIL-1RA were above the detectable limit of assay in ~89% of enrolled patients.